Home/Filings/4/0001127602-25-008037
4//SEC Filing

Allouche Danny Gilad 4

Accession 0001127602-25-008037

CIK 0000008818other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 6:54 PM ET

Size

37.5 KB

Accession

0001127602-25-008037

Insider Transaction Report

Form 4
Period: 2025-03-01
Allouche Danny Gilad
SVP, CSDO & Interim CFO
Transactions
  • Exercise/Conversion

    Common Stock

    2025-03-01$187.06/sh+376$70,33518,981 total(indirect: By Trust)
  • Tax Payment

    Common Stock

    2025-03-01$187.06/sh169$31,61318,812 total(indirect: By Trust)
  • Tax Payment

    Common Stock

    2025-03-01$187.06/sh165$30,86519,248 total(indirect: By Trust)
  • Exercise/Conversion

    Common Stock

    2025-03-01$187.06/sh+233$43,58519,481 total(indirect: By Trust)
  • Tax Payment

    Common Stock

    2025-03-01$187.06/sh86$16,08719,395 total(indirect: By Trust)
  • Exercise/Conversion

    Common Stock

    2025-03-01$187.06/sh+811$151,70620,206 total(indirect: By Trust)
  • Award

    2025 MSU Award

    2025-03-01+2,4632,463 total
    Exercise: $0.00From: 2026-03-01Exp: 2029-03-01Common Stock (2,463 underlying)
  • Award

    2025 Promotion RSU Award

    2025-03-01+2,6732,673 total
    Exercise: $0.00From: 2028-03-01Exp: 2028-03-01Common Stock (2,673 underlying)
  • Exercise/Conversion

    2022 MSU Award

    2025-03-01458473 total
    Exercise: $0.00From: 2023-03-01Exp: 2026-03-01Common Stock (458 underlying)
  • Exercise/Conversion

    Common Stock

    2025-03-01$187.06/sh+458$85,67319,270 total(indirect: By Trust)
  • Tax Payment

    Common Stock

    2025-03-01$187.06/sh202$37,78619,068 total(indirect: By Trust)
  • Exercise/Conversion

    Common Stock

    2025-03-01$187.06/sh+345$64,53619,413 total(indirect: By Trust)
  • Tax Payment

    Common Stock

    2025-03-01$187.06/sh357$66,78019,849 total(indirect: By Trust)
  • Award

    2025 PU Award

    2025-03-01+2,5642,564 total
    Exercise: $0.00From: 2028-03-01Exp: 2028-03-01Common Stock (2,564 underlying)
  • Exercise/Conversion

    2021 MSU Award

    2025-03-013760 total
    Exercise: $0.00From: 2022-03-01Exp: 2025-03-01Common Stock (376 underlying)
  • Exercise/Conversion

    2023 MSU Award

    2025-03-01345696 total
    Exercise: $0.00From: 2024-03-01Exp: 2027-03-01Common Stock (345 underlying)
  • Exercise/Conversion

    2024 MSU Award

    2025-03-01233742 total
    Exercise: $0.00From: 2025-03-01Exp: 2028-03-01Common Stock (233 underlying)
  • Exercise/Conversion

    2022 PU Award

    2025-03-018110 total
    Exercise: $0.00From: 2025-03-01Exp: 2025-03-01Common Stock (811 underlying)
Footnotes (8)
  • [F1]Market-leveraged stock units (MSUs) vest 25% over one-, two-, three- and four-year performance periods, with the number of shares paid on each vesting date based on our absolute total stockholder return. Each MSU represents a contingent right to receive one share of common stock, plus dividend equivalents accrued during the vesting period.
  • [F2]Performance units (PUs) vest, at the end of fiscal year 2027, provided certain performance objectives are met as determined by the Compensation Committee in February 2028. Each PU represents a contingent right to receive one share of common stock.
  • [F3]Restricted stock units (RSUs) cliff vest on the third anniversary of the grant date. Each RSU represents a contingent right to receive one share of common stock.
  • [F4]Shares reflect the vesting of the fourth tranche of MSUs granted in February 2021 at 128% of target based on our absolute total stockholder return in excess of 10% during the 2021-2024 performance period, plus dividend equivalents accrued during the period.
  • [F5]Shares reflect the vesting of the third tranche of MSUs granted in March 2022 at 92% of target based on our absolute total stockholder return during the 2022-2024 performance period, plus dividend equivalents accrued during the period.
  • [F6]Shares reflect the vesting of the second tranche of MSUs granted in March 2023 at 96% of target based on our absolute total stockholder return during the 2023-2024 performance period, plus dividend equivalents accrued during the period.
  • [F7]Shares reflect the vesting of the first tranche of MSUs granted in March 2024 at 93% of target based on our absolute total stockholder return during the 2024 performance period, plus dividend equivalents accrued during the period.
  • [F8]Shares reflect the vesting of PUs granted in March 2022 at 50% of target, based 50% on our cumulative economic value added of 0% of target and 50% on our capped relative total stockholder return of 100% of target.

Issuer

Avery Dennison Corp

CIK 0000008818

Entity typeother

Related Parties

1
  • filerCIK 0002045672

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:54 PM ET
Size
37.5 KB